Clinical trialNCT03825094UnknownObservational

DyeVert™ System for Contrast Monitoring in At-Risk Patients Undergoing Angiography: A Real-World Registry

SponsorOsprey Medical, IncEnrollment10,000Patients at Risk for Developing Contrast-induced Nephropathy

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this registry-based study is to evaluate the ongoing, real-world clinical performance and safety of commercially available DyeVert Systems during typical clinical use for patients undergoing coronary or peripheral angiography for diagnostic and/or interventional procedures.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Anand Prasad, MD, FACC
UT Health Science Center San Antonio: Prof of Medicine & Director Cardiac Catheterization Laboratory
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Hartford Healthcare
Hartford, Connecticut, United States
Steward Palmetto General Hospital
Hialeah, Florida, United States
Emory Healthcare
Atlanta, Georgia, United States
Atlanta Va Medical Center
Decatur, Georgia, United States
Midwest Heart & Vascular Specialists
Overland Park, Kansas, United States
St. Elizabeth Healthcare
Edgewood, Kentucky, United States
North Mississippi Medical Center
Tupelo, Mississippi, United States
Christus Health-Westover Hills
San Antonio, Texas, United States
the University of Texas Health Science Center
San Antonio, Texas, United States
St. Mary'S Medical Center
Huntington, West Virginia, United States
West Virginia University
Morgantown, West Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 7 May 2019
Primary completion: 31 Dec 2023
Completion: 31 Dec 2023
Last update posted: 18 Apr 2022
Registered enrollment: 10,000
Registry id: NCT03825094

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.